NCT03302962

Brief Summary

Asthma is a chronic lung disease with serious morbidity and potential mortality. Multiple physiologic, environmental and social conditions impact the prevalence and severity of asthma. Even when diagnosed, effective control can be impeded by improper use of medication, not understanding or being unable to avoid environmental triggers, lack of continuity in follow-up care, and lack of an asthma action plan. American Indians are especially at-risk for health problems related to asthma. American Indians have the highest asthma rate among single-race groups; 18.5% of American Indians are diagnosed with asthma, while only 11% are diagnosed with asthma in the general population but little is known about why this is true. Asthma is a prototypic example of the interaction of biologic, environmental and psychosocial influences on disease and this study investigated the possible improvement in asthma control from an intensive educational intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
324

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 14, 2013

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 29, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 5, 2017

Completed
Last Updated

October 5, 2017

Status Verified

October 1, 2017

Enrollment Period

4.2 years

First QC Date

September 29, 2017

Last Update Submit

October 4, 2017

Conditions

Keywords

asthmapediatricamerican indianchildren

Outcome Measures

Primary Outcomes (1)

  • Chart Review of ED Visits

    Emergency room visits for pulmonary complaints

    3 years

Study Arms (2)

Intensive Asthma Education

EXPERIMENTAL

One half (54) of the identified cases were randomized to receive the previously established "BREATHE" study educational program, emphasizing patient-centered, self management of asthma. Periodic follow-up through personal contact and surveillance of IHS RPMS or other medical provider records was conducted.

Behavioral: Intensive Asthma Education

Routine Asthma Education Literature

NO INTERVENTION

The remaining 54 cases were randomized to the "control" arm and received written materials related to patient-centered asthma control.

Interventions

One half (54) of the identified cases were randomized to receive the previously established "BREATHE" study educational program, emphasizing patient-centered, self management of asthma. Periodic follow-up through personal contact and surveillance of IHS RPMS or other medical provider records was conducted.

Intensive Asthma Education

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Cases must be "American Indian" (eligibile for care within the Indian Health Service); and at least 2 of the following 3 criteria:
  • a diagnosis of asthma on at least 2 occasions by more than one provider during the past 2 years.
  • refills of asthma treatment medications on at least 2 occasions during the past 2 years.
  • Improvement of spirometry FEV1 of 20% with use of albuterol MDI or nebulizer.
  • Controls meet the same demographic criteria as cases, but must also meet all of the following criteria.
  • No diagnosis of asthma by any provider during the past 2 years.
  • No prescriptions of any asthma meds during the past 2 years.

You may not qualify if:

  • Birthweight less than 2500 grams
  • Neonatal ventilator treatment
  • Hospitalization at birth greater than 15 days.
  • Congenital heart anomaly requiring surgery
  • Diagnosis of cystic fibrosis
  • Congenital lung, diaphragm, chest wall, or airway anomaly
  • Diagnosis of pneumonia, pertussis, or tuberculosis within the past year
  • Congenital muscular disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Missouri Breaks Industries Research Inc.

Eagle Butte, South Dakota, 57625, United States

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2017

First Posted

October 5, 2017

Study Start

March 14, 2013

Primary Completion

May 25, 2017

Study Completion

May 25, 2017

Last Updated

October 5, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

This study was conducted by permission of the Cheyenne River Sioux Tribe and data sharing is allowed only with their permission. Any investigators wishing to access data from the study should contact Missouri Breaks Industries Research Inc for information on application procedures.

Locations